日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Regeneration of Two-Walled Infrabony Periodontal Defects in Swine After Buccal Fat Pad-Derived Dedifferentiated Fat Cell Autologous Transplantation.

颊脂垫来源的去分化脂肪细胞自体移植后猪双壁骨内牙周缺损的再生

Akita Daisuke, Tsukimura Naoki, Kazama Tomohiko, Takahashi Rie, Taniguchi Yoshiki, Inoue Jin, Suzuki Ayana, Tanabe Nodoka, Seki Keisuke, Arai Yoshinori, Asano Masatake, Sato Shuichi, Hagiwara Yoshiyuki, Kano Koichiro, Honda Masaki, Matsumoto Taro

Evaluation of GLA variants detected in newborn screening for Fabry disease using biomarker analysis

利用生物标志物分析评估新生儿法布里病筛查中检测到的GLA变异体

Sawada, Takaaki; Kido, Jun; Tsukimura, Takahiro; Sugawara, Keishin; Shiga, Tomoko; Saito, Seiji; Togawa, Tadayasu; Inoue, Takahito; Watanabe, Yoriko; Hamada, Junpei; Sakuraba, Hitoshi; Nakamura, Kimitoshi

Comparative study on incorporation of three recombinant human α-galactosidase A drugs (agalsidases) into cultured fibroblasts and organs/tissues of Fabry mice

三种重组人 α-半乳糖苷酶 A 药物(阿加糖苷酶)与法布里病小鼠培养成纤维细胞和器官/组织结合的比较研究

Takahiro Tsukimura, Tomoko Shiga, Tadayasu Togawa, Hitoshi Sakuraba

Does administration of hydroxychloroquine/amiodarone affect the efficacy of enzyme replacement therapy for Fabry mice?

羟氯喹/胺碘酮的使用是否会影响法布里小鼠酶替代疗法的疗效?

Takahiro Tsukimura, Koki Saito, Tomoko Shiga, Yasuhiro Ogawa, Hitoshi Sakuraba, Tadayasu Togawa

Profiles of Globotriaosylsphingosine Analogs and Globotriaosylceramide Isoforms Accumulated in Body Fluids from Various Phenotypic Fabry Patients

不同表型法布里病患者体液中积累的球状三己糖鞘氨醇类似物和球状三己糖神经酰胺同工型的分析

Shiga, Tomoko; Tsukimura, Takahiro; Kubota, Takao; Togawa, Tadayasu; Sakuraba, Hitoshi

Effects of switching from agalsidase-α to agalsidase-β on biomarkers, renal and cardiac parameters, and disease severity in fabry disease forming neutralizing antidrug antibodies: a case report

阿加糖酶-α 换用阿加糖酶-β 对法布里病患者生物标志物、肾脏和心脏参数以及疾病严重程度的影响:一例中和抗药抗体的病例报告

Shima, Hisato; Tsukimura, Takahiro; Shiga, Tomoko; Togawa, Tadayasu; Sakuraba, Hitoshi; Doi, Toshio; Ikeda, Yuka; Okamoto, Takuya; Yoshikawa, Yukari; Kimura, Takehiko; Iwase, Takashi; Inoue, Tomoko; Tashiro, Manabu; Okada, Kazuyoshi; Minakuchi, Jun

A universal GlycoDesign for lysosomal replacement enzymes to improve circulation time and biodistribution

一种用于溶酶体替代酶的通用糖基化设计,旨在改善循环时间和生物分布。

Chen, Yen-Hsi; Tian, Weihua; Yasuda, Makiko; Ye, Zilu; Song, Ming; Mandel, Ulla; Kristensen, Claus; Povolo, Lorenzo; Marques, André R A; Čaval, Tomislav; Heck, Albert J R; Sampaio, Julio Lopes; Johannes, Ludger; Tsukimura, Takahiro; Desnick, Robert; Vakhrushev, Sergey Y; Yang, Zhang; Clausen, Henrik

In Vivo Delivery of Therapeutic Molecules by Transplantation of Genome-Edited Induced Pluripotent Stem Cells

通过移植基因组编辑的诱导性多能干细胞进行体内治疗分子递送

Ittetsu Nakajima, Takahiro Tsukimura, Terumi Ono, Tomoko Shiga, Hiroshi Shitara, Tadayasu Togawa, Hitoshi Sakuraba, Yuichiro Miyaoka

Monitoring of anti-drug antibodies and disease-specific biomarkers in three patients from a Japanese Fabry family treated with enzyme replacement therapy

对接受酶替代疗法治疗的三名来自日本法布里病家族的患者进行抗药抗体和疾病特异性生物标志物监测

Kubota, Takao; Tsukimura, Takahiro; Shiga, Tomoko; Togawa, Tadayasu; Sakuraba, Hitoshi

Pharmacokinetic Assessment and Treatment Effect of Lusutrombopag in Child-Pugh Class C Patients: Review of Patient Data from Two Clinical Studies and Post-Marketing Surveillance

鲁苏曲波帕在Child-Pugh C级患者中的药代动力学评估和治疗效果:两项临床研究和上市后监测的患者数据回顾

Flamm, Steven L; Peck-Radosavljevic, Markus; Fukuhara, Takahiro; Bentley, Roy; Katsube, Takayuki; Ochiai, Toshimitsu; Kano, Takeshi; Tsukimura, Eri; Sasaki, Ritsue; Osaki, Yukio